Volume 11.03 | Jan 27

ESC & iPSC News 11.03 January 27, 2016
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC on Twitter
 
TOP STORY
Lineage-Specific Enhancers Activate Self-Renewal Genes in Macrophages and Embryonic Stem Cells
The authors showed that in mice, the transcription factors MafB and c-Maf repress a macrophage-specific enhancer repertoire associated with a gene network controlling self-renewal. The network controlled embryonic stem cell self-renewal but is associated with distinct embryonic stem cell-specific enhancers. [Science] Abstract
Request your Free Wallchart on Naive and Primed Stem Cell States
 
PUBLICATIONS (Ranked by impact factor of the journal)
Isolation and Cultivation of Naive-Like Human Pluripotent Stem Cells Based on HERVH Expression
Investigators describe a protocol for genetic and phenotypic tagging, selecting and maintaining naive-like human pluripotent stem cells. [Nat Protoc] Abstract | Press Release

H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs
Scientists investigated the function of H2A.Z.1 monoubiquitylation by mutation of the PRC1 target residues (H2A.Z.1K3R3). They showed that H2A.Z.1K3R3 is properly incorporated at target promoters in murine embryonic stem cells, but loss of monoubiquitylation leads to de-repression of bivalent genes, loss of Polycomb binding, and faulty lineage commitment. [Cell Rep] Full Article | Graphical Abstract

Serum-Based Culture Conditions Provoke Gene Expression Variability in Mouse Embryonic Stem Cells as Revealed by Single-Cell Analysis
Researchers performed single-cell mRNA-seq analysis of mouse embryonic stem cells (ESCs) and uncovered significant heterogeneity in ESCs cultured in serum. They defined highly variable gene clusters with distinct chromatin states and show that bivalent genes are prone to expression variation. [Cell Rep]
Full Article | Graphical Abstract

Genetic Variation, Not Cell Type of Origin, Underlies the Majority of Identifiable Regulatory Differences in iPSCs
The authors found a remarkably small number of differences in DNA methylation and gene expression levels between induced pluripotent stem cells (iPSCs) derived from different somatic precursors. They demonstrated genetic variation is associated with the majority of identifiable variation in DNA methylation and gene expression levels. [PLoS Genet] Full Article

Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells
Scientists tested whether CRISPR/Cas9 could be used in patient-specific induced pluripotent stem cells to precisely repair an RPGR point mutation that causes X-linked retinitis pigmentosa. [Sci Rep] Full Article | Press Release

GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells
Scientists generated transgene-free induced pluripotent stem cells (iPSCs) from different non-human primate species and showed the efficient induction of mesoderm, myeloid, and lymphoid cells from these iPSCs using a GSK3β inhibitor. [Stem Cell Reports] Full Article | Graphical Abstract

NANOG Binds to GLI Proteins and Represses Hedgehog-Mediated Transcription
To study the transcriptional response of stem cells to Hedgehog (HH) signaling, investigators searched for proteins binding to GLI proteins, the transcriptional effectors of the HH pathway in mouse embryonic stem (ES) cells. They found that both GLI3 and GLI1 bind to the pluripotency factor NANOG. [J Biol Chem]
Abstract | Full Article

Embryonic Stem Cells Exhibit mRNA Isoform Specific Translational Regulation
Researchers investigated the differential translation rates of individual mRNA variants in embryonic stem cells (ESCs) and in ESC derived Neural Precursor Cells using polysome profiling coupled to RNA sequencing. [PLoS One] Full Article

Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells
Mouse embryonic stem cells and reprogrammed induced pluripotent stem cells, as well as the original un-reprogrammed embryonic fibroblasts, were evaluated for expression of cytoskeletal markers. Scientists found that pluripotent stem cells overall have a less developed cytoskeleton compared to fibroblasts. [PLoS One] Full Article

Request a Sample for Improved Neuronal Function with BrainPhys™ Neuronal Medium
 
REVIEWS
Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration
The authors review various strategies currently used for β cell reprogramming, including ectopic expression of specific transcription factors associated with islet development, repression of maintenance factors of host cells, regulation of epigenetic modifications, and microenvironmental changes. [Trends Endocrinol Metab] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.
 
INDUSTRY NEWS
Asterias Biotherapeutics Announces Completion of Transfer of AST-VAC2 Manufacturing Process to Cancer Research UK as Milestone Towards Initiating Phase I/II Clinical Trial
Asterias Biotherapeutics, Inc. announced that it has completed the transfer of its manufacturing processes to produce AST-VAC2 to Cancer Research UK. AST-VAC2 is an innovative immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells. [Asterias Biotherapeutics, Inc. (PR Newswire Association LLC.)] Press Release

$2.5 Million Grant Awarded to Sac State Stem Cell Program
A $2.5 million grant awarded to Sacramento State’s Bridges to Stem Cell Research and Therapy Program will help an additional 50 biological science students get a master of arts degree in 20 months. [California State University, Sacramento] Press Release

From our sponsor: Culturing hematopoietic stem and progenitor cells? Download the technical bulletin.
 
POLICY NEWS
Researchers Question Design of Fatal French Clinical Trial
Scientists are voicing concerns over the design of a French drug trial that left one participant dead and several others with severe health problems — and they are calling for more information to be released. [Nature News] Editorial

U.S. Charges Drug Researchers with Sending Trade Secrets to China, but Will Case Stand Up?
Attorneys are urging caution in evaluating the strength of a U.S. trade secrets case against two GlaxoSmithKline scientists who were accused last week of transferring trade secrets to China. [ScienceInsider] Editorial
 
EVENTS
NEW Cell Symposia – 10 Years of iPSCs
September 25-27, 2016
Berkeley, United States

Visit our events page to see a complete list of events in the ESC & iPSC community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Candidate – Embryonic Stem Cells and Chromatin Biology (University of Michigan)

Postdoctoral Position – Genetics and Genomics of Stem Cells (Albert Einstein College of Medicine of Yeshiva University)

Postdoctoral Fellow – Bioinformatics and Stem Cell Biology (University of Texas)

Development Engineer/Scientist – Regenerative Medicine (Centre for Commercialization of Regenerative Medicine)

Postdoctoral Fellow – Cell and Developmental Biology (The Francis Crick Institute)

Postdoctoral Research Associate – Developmental and Stem Cell Biology (University of Cambridge)

Science Content Writer (Howard Hughes Medical Institute)

Stem Cell Production Scientist (Definigen Ltd)

Scientist – Cell Biology (Semma Therapeutics)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about ESC & iPSC News: Archives | Events | Contact Us